Danaher Beats Estimates as Diagnostics Sales Increase -- Earnings Review
January 30 2018 - 6:50AM
Dow Jones News
By Cara Lombardo
Danaher Corp. (DHR) reported its fourth-quarter earnings
Tuesday. Here's what you need to know:
EARNINGS: Danaher reported net income of $856.6 million, or
$1.21 a share. Excluding the impact of the new tax law and other
one-time items, the company earned $1.19 a share. Analysts polled
by Thomson Reuters had expected adjusted earnings of $1.16 a
share.
REVENUE: Revenue increased 11% to $5.1 billion, more than the $5
billion analysts had expected. Diagnostics sales jumped more than
13%, while sales in the company's environmental and and life
sciences units rose around 12%. Dental sales increased the least,
by 3%.
GUIDANCE: The medical equipment company guides 1Q adjusted EPS
between 90 cents and 93 cents and full year adjusted EPS between
$4.25 to $4.35.
CFO SWITCH: Matthew McGrew, the current CFO of the company's
diagnostics and dental platforms, will take over for CFO Daniel
Comas on Jan. 1, 2019. Mr. Comas will continue as an executive vice
president as he transitions to retirement. Mr. McGrew has been with
the company since 2004.
Write to Cara Lombardo at cara.lombardo@wsj.com
(END) Dow Jones Newswires
January 30, 2018 06:35 ET (11:35 GMT)
Copyright (c) 2018 Dow Jones & Company, Inc.
Danaher (NYSE:DHR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Danaher (NYSE:DHR)
Historical Stock Chart
From Apr 2023 to Apr 2024